SCHEMBL23217900

SCHEMBL23217900

Cc1cccc(C(=O)C(=O)c2ccc3ncc(OCCNC(=O)OC(C)(C)C)nc3c2)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA5 P31644 1/20 0.38
LATS1 O95835 2/20 0.37
PDK2 Q15119 1/20 0.37
SCN9A Q15858 1/20 0.37
NQO2 P16083 1/20 0.37
NAMPT P43490 5/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
CKS1B P61024 1/20 0.36
SKP1 P63208 1/20 0.36
SKP2 Q13309 1/20 0.36
SUCNR1 Q9BXA5 1/20 0.36
EGFR P00533 1/20 0.35
ITK Q08881 1/20 0.35
KDM4E B2RXH2 1/20 0.35
POLB P06746 1/20 0.35
BRD4 O60885 2/20 0.35
NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23217910 0.86 CA12 (0.40) GABRA5LATS1PDK2SCN9ACA12
SCHEMBL23217953 0.85 PDK2 (0.36) PDK2SCN9ANQO2NAMPTCA12
SCHEMBL23217897 0.81 NPC1 (0.34) GABRA5LATS1NAMPTCKS1BSKP1
SCHEMBL23217974 0.78 CA12 (0.43) LATS1PDK2SCN9ANQO2CA12
SCHEMBL23217968 0.76 KDM4E (0.48) LATS1PDK2SCN9ANQO2CA12
SCHEMBL30131266 0.76 CA12 (0.49) PDK2SCN9ANQO2CA12CA1
SCHEMBL23217944 0.75 TGFBR1 (0.48) CKS1BSKP1SKP2SUCNR1
SCHEMBL23217959 0.73 TGFBR1 (0.41) CKS1BSKP1SKP2SUCNR1EGFR
SCHEMBL23217905 0.73 CA12 (0.40) PDK2SCN9ACA12CA1CA2
SCHEMBL23217923 0.71 NPC1 (0.40) KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022006340-A1 ALK5 INHIBITORS, CONJUGATES, AND USES THEREOF SILVERBACK THERAPEUTICS, INC. (US) 2022-01-06 WO disclosed
WO-2022006340-A1 ALK5 INHIBITORS, CONJUGATES, AND USES THEREOF SILVERBACK THERAPEUTICS, INC. (US) 2022-01-06 WO disclosed
WO-2021072330-A1 GALNAC-TGFBR1 INHIBITOR CONJUGATES FOR THE TREATMENT OF LIVER DISEASES SILVERBACK THERAPEUTICS, INC. (US) 2021-04-15 WO disclosed